Update on dalbavancin activity tested against Gram-positive clinical isolates responsible for documented skin and skin-structure infections in US and European hospitals (2011-13).

Update on dalbavancin activity tested against Gram-positive clinical isolates responsible for documented skin and skin-structure infections in US and European hospitals (2011-13). by Mendes RE, Castanheira M, Farrell DJ, Flamm RK, Sader HS and Jones RN. published in J. Antimicrob. Chemother. 2016; 71 (1): 276-278